KK

Kundur Kunjipengan Saseendran

Active Director Managing Director DIN 10156790
DIN 10156790 First appointment May 2023 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Kundur Kunjipengan Saseendran

Data last updated:

Kundur Kunjipengan Saseendran is a Managing Director at Sciquest Pharma Innovations India Private Limited (since 2023). The company operates in Paper.

DIN 10156790
Primary Designation Managing Director
Industry Paper
First Appointment 10 May 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Managing Director10 May 20232023Active

Board colleagues of Kundur Kunjipengan Saseendran

Directorship timeline

Open interactive timeline →
Sciquest Pharma Innovations India Private Limited
Premium access

Shareholding and investment profile for Kundur Kunjipengan Saseendran

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kundur Kunjipengan Saseendran

Kundur Kunjipengan Saseendran currently holds 1 directorship: Sciquest Pharma Innovations India Private Limited (Managing Director, since 10 May 2023).

Kundur Kunjipengan Saseendran was first appointed on 10 May 2023 as Managing Director at Sciquest Pharma Innovations India Private Limited.

The current boards of Kundur Kunjipengan Saseendran's companies include Vincy Kunhiramante Valappil (Sciquest Pharma Innovations India Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available